Marshall S. Stanton, SVP, Clinical & MD Affair at ARTIVION, INC. (AORT), sold 30,552 shares at $44.28 ($1.3M) on 2025-11-20, disclosed to the SEC on 2025-11-24.
Open-market sale of $1.3M AORT by SVP, Clinical & MD Affair. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $44.14 | 11,888 | $525K | 38.9% |
| 2 | $44.14 | 11,888 | $525K | 38.9% |
| 3 | $44.28 | 1,355 | $60K | 4.4% |
| 4 | $44.28 | 1,355 | $60K | 4.4% |
| 5 | $44.32 | 2,033 | $90K | 6.7% |
| 6 | $44.32 | 2,033 |
| $90K |
| 6.7% |
| Total | $44.18 avg | 30,552 | $1.3M | 100% |
| Filing → |
| AORT | SELL | 2026-02-25 | $136K | — | Filing → |
| AORT | SELL | 2025-11-24 | $4.3M | — | Filing → |
| AORT | SELL | 2025-11-14 | $458K | — | Filing → |